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Abstract 
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of cognitive status on function and participation in daily activities, and explore how cancer survivors 
perceive changes in their cognition. The study used a quantitative nonexperimental cross-sectional 
design. The participants included 35 cancer survivors from two different sites. Instruments included the 
Montreal Cognitive Assessment (MoCA) and the Reintegration to Normal Index-Postal Version (RNLI-P) in 
the measurement of cognitive impairment and functional performance respectively. Data were also 
collected with a supplemental questionnaire to explore participants’ perspectives on their cognitive 
difficulties and current function. The participant scores on the MoCA indicated cognitive impairment (µ= 
25) and their scores on the RNLI-P demonstrated subpar reintegration (µ=9.64). Twenty-one participants 
answered the supplemental questionnaire. In content analysis of questionnaire responses, 17/21 
participants reported some level of cognitive change related to cancer and cancer treatment. Data from 
an open-ended question were organized into four categories: decreased participation, more selective in 
activities, balance in activities, and cognitive changes. Study results indicate a large percentage of cancer 
survivors demonstrate mild cognitive impairment as well as changes in participation in instrumental 
activities of daily living. 
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 Advances in research and treatment 
techniques have resulted in a growing number of 
cancer survivors (Cohen, 2010).  However, with 
these new advancements come new concerns.  
Changes in cognition have been identified as an 
effect of cancer treatment in an estimated one-third 
of cancer patients and survivors (Raffa et al., 2006).  
Research has shown that symptoms associated with 
mild cognitive impairments (MCIs), including 
difficulty with new learning, forgetfulness, and 
managing daily activities, are prevalent among 
cancer survivors (Baxter, Dulworth, & Smith, 2011; 
Jenkins et al., 2006; Tannock, Ahles, Ganz, & van 
Dam, 2004).  Consequently, a concern for cancer 
survivors is how cognitive impairments might affect 
their function and life participation after treatment.  
To date, there has been limited research on how 
cognitive changes caused by cancer treatment affect 
survivors’ participation in daily activities.  
Background 
Cognitive Changes and Daily Function 
 Tannock et al. (2004) found that cancer 
survivors had concerns about cognition, in 
particular memory and concentration, following 
treatment.  Ahles and Saykin (2001) noted similar 
findings across patients with different cancers who 
received systematic standard-dose chemotherapy.  
The participants in the study by Ahles and Saykin 
reported that cognitive impairments interfered with 
their career and educational goals, as well as with 
everyday functioning.  In a more recent study, 
Baxter et al. (2011) found that of 38 participants, 
several encountered a decrease or change in their 
participation in everyday life, including physical 
and leisure activities.  In a longitudinal randomized 
study, Kvale et al. (2010) determined that 
participants showed cognitive impairments that led 
to difficulty with instrumental activities of daily 
living (IADLs), particularly those associated with 
driving.  These difficulties contributed to 
disabilities among the participants by affecting their 
ability to perform daily tasks.   
 Much of the research involving cancer-
related cognitive impairment is found in studies 
with breast cancer survivors.  For example, Jenkins 
et al. (2006) reported that of 128 breast cancer 
survivors, 83% noticed changes in memory and 
80% noticed a change in concentration.  These 
changes decreased to 60% and 45%, respectively, 
after three years.  In another study of 52 breast 
cancer survivors, 17-25% showed significant 
cognitive impairments following cancer treatment 
(Von Ah et al., 2009).  Reid-Arndt, Hsieh, and 
Perry (2010) demonstrated that cognitive 
impairments continue to be prevalent up to one year 
after treatment has ended.  Moreover, these 
impairments have been shown to have an effect on 
daily tasks, such as the ability to make employment 
decisions and return to work (Munir, Burrows, 
Yarker, Kalawsky, & Bains, 2010).  Breast cancer 
patients have also expressed similar cognitive 
dysfunctions after receiving adjuvant therapy (i.e., 
additional chemotherapy, radiation, or other 
treatment) to decrease cancer reoccurrence.  In a 
study by Shilling and Jenkins (2007), 142 breast 
cancer patients reported cognitive impairments, 
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 particularly with memory (71%) and concentration 
(64%).  The use of Tamoxifen, an anti-estrogen 
drug taken by premenopausal breast cancer patients, 
has been shown to result in widespread cognitive 
impairments (Palmer, Trotter, Joy, & Carlson, 
2008). 
Cancer survivors across many diagnoses, 
including gastrointestinal, lung, lymphoma, head 
and neck, prostate, and breast cancer, have reported 
difficulties with activities requiring cognitive 
functioning many months and years after 
completing treatment (Mah, Bezjak, Loblaw, 
Gotowiec, & Devins, 2011).  Grosshans, Meyes, 
Allen, Davenport, and Komaki (2008) found that 
persons with lung cancer receiving radiation 
showed a decrease in both executive function and 
language.  It has also been estimated that 15% of 
persons with small-cell lung cancer may experience 
cognitive impairments following treatment (Kanard, 
Frytak, & Jatoi, 2004).  In a study by Schagen et al. 
(2008), 50% of testicular cancer survivors (N = 70) 
reported cognitive impairments following 
chemotherapy treatment.  In addition, difficulties 
with verbal memory and motor speed were evident 
in persons diagnosed with lymphoma cancers for up 
to two years following treatment (Correa et al., 
2009).   
MCI and Daily Function   
MCI is defined as an intermediate clinical 
state between normal cognitive function and 
dementia that focuses primarily on memory, 
concentration, and attention (Petersen, 2004).  In 
recent years, it has been researched as a diagnostic 
entity to be used with a variety of populations, 
including the cancer population.  Results of a study 
by Tuokko (2007) found that 69% of participants 
with MCI (N = 101) demonstrated functional 
impairment, particularly involving memory and 
executive function.  In a study by Baxter et al. 
(2011), of the 25 cancer patients reporting difficulty 
with memory, planning, or attention, 36% scored as 
having a mild cognitive impairment.  
 Farias et al. (2006); Perneczky et al. (2006); 
and Artero, Touchon, and Ritchie (2001) all 
concluded that persons with MCI are affected by 
cognitive impairments, which can result in a wide 
range of deficits in everyday life.  Kurz, Pohl, 
Ramsenthaler, and Sorg (2009) have suggested that 
MCI interferes with social planning, such as 
structuring and maintaining social contacts.  
Maintaining the social aspects of life is an important 
domain in quality of life (QoL) among cancer 
survivors (Bloom, Petersen, & Kang, 2007).  In a 
large study of breast cancer survivors receiving 
adjuvant and/or Tamoxifen therapy (N = 763), 30% 
were shown to have poorer functioning on several 
dimensions of QoL (Ganz et al., 2002).  
More specifically, Okonkwo, Wadley, 
Griffith, Ball, and Marson (2006) and O’Connor, 
Edwards, Wadley, and Crowe (2010) suggested that 
persons with MCI have trouble with a variety of 
IADLs, including difficulties with telephone use, 
transportation, shopping, meal preparation, 
housework, medications, and money management.  
Chirikos, Russell-Jacobs, and Jacobsen (2002) 
reported that these impairments are likely to affect 
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 work effort and earnings.  In a study investigating 
persons with MCI and money management, 
Okonkwo et al. (2006) found that persons with MCI 
made more errors affecting work effort, earnings, 
and overall economic status. Persons with MCI also 
have increased difficulty using technology, such as 
cell phones, remote controls, microwave ovens, and 
computers.  These technological tools are important 
for daily life, and difficulty using them can impede 
daily function and participation (Rosenberg, 
Kottorp, Winblad, & Nygard, 2009).  
Adequate cognitive function is crucial to 
performing IADLs associated with function and 
participation.  However, there is limited literature 
that relates cognitive dysfunction to cancer 
survivors’ daily participation.  Further research is 
needed to identify evidence-based interventions 
geared toward life participation.   
Method 
Purpose of Study 
Initially, this study had two purposes.  The 
first was to identify the posttreatment cognitive 
status in a population of cancer survivors.  The 
second was to determine how these changes 
affected their function and participation in daily life 
activities.  A third purpose was eventually added, 
which explored how cancer survivors perceived 
changes in their cognition. 
Research Design 
 This study used a nonexperimental cross-
sectional design to explore quantitative data 
relevant to cancer-related cognitive changes.  
Measures were taken for attention, concentration, 
executive function, memory, calculation, and 
orientation related to mild cognitive impairment, as 
well as how well the participants engaged in daily 
activities.  Data gathered by questionnaire included 
participants’ perceptions of how cancer treatments 
and MCI affected their daily routines and 
participation in activities.  This study was a 
collaborative project completed in Towson, 
Maryland, and Houston, Texas. 
Participants 
The participants recruited for this study were 
adult cancer survivors.  The operational definition 
of cancer survivor was an individual with a 
diagnosis of cancer who had completed primary 
treatment for cancer.  Inclusion criteria were that 
participants had the physical language and visual 
abilities needed to complete the assessments.  No 
exclusion criteria were placed on cancer type, 
gender, ethnicity, or adult age. 
Instruments 
 The instruments used included the Montreal 
Cognitive Assessment (MoCA) (Nasreddine et al., 
2005), the Reintegration to Normal Living Index–
Postal Version (RNLI-P) (Daneski, Coshall, 
Tillingand, & Wolfe, 2003), and a supplemental 
questionnaire.  The MoCA is a screening tool 
designed to detect MCI that takes approximately 10 
min to administer.  The tool assesses different 
cognitive domains: attention, concentration, 
executive functions, memory, language, visuospatial 
skills, conceptual thinking, calculations, and 
orientation.  The MoCA has been used previously to 
detect MCI in several populations, including 
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 persons with Alzheimer’s disease, Huntington’s 
disease, Parkinson’s disease, cardiovascular disease, 
and brain metastases.  The highest possible score on 
the MoCA is 30 points, and a score of 26 or above is 
considered normal.  When compared to normal 
controls, the MoCA has a sensitivity level of 87% for 
normal controls and 90% for persons exhibiting an 
MCI.  The test-retest reliability coefficient is .92, 
with an internal consistency measured by Cronbach’s 
alpha at 0.83.  The MoCA has been demonstrated to 
be sensitive in identifying MCI in aging adults 
compared to age-matched controls and age-matched 
persons diagnosed with dementia (Nasreddine et al., 
2005).   
The RNLI was developed in 1988 to assess 
life participation by measuring how well an 
individual returns to normal living patterns following 
an incapacitating diseases or injury (Wood-
Dauphinee, Opzoomer, Williams, Marchand, & 
Spitzer, 1988).  The RNLI used a visual analog scale 
to assess participants’ perceptions on 11 declarative 
statements representing domains of daily 
functioning (e.g., mobility and self-care), daily 
activities (e.g., work, recreational, and social 
activities), roles and personal relationships, and 
general coping skills.  The RNLI was found to have 
an internal consistency, as measured by Cronbach’s 
alpha, of 0.90 (Wood-Dauphinee et al., 1988) and a 
concurrent validity of 0.72 (Spitzer, Dobson, & Hall, 
1981).  
In 2003, the RNLI was revised as a postal 
version and was renamed the RNLI-P.  To complete 
the RNLI-P, the participants answer 11 questions by 
choosing “agree” or “disagree” (Daneski et al., 
2003).  One point is given for each agree statement, 
and zero points for each disagree statement.  The 
lowest score possible is a 0.  The highest score, 11, 
indicates maximum integration.  Reliability measures 
have shown that the RNLI-P is an excellent measure 
of reintegration into life following a traumatic event 
or injury.  The test-retest reliability of the RNLI-P, as 
measured by the kappa level, is 0.92 (Daneski et al., 
2003).  
The supplemental questionnaire was 
designed by the researchers (and had been used in a 
previous study) to obtain more in-depth information 
regarding the participants’ perceptions of cognitive 
dysfunction and their current abilities to function and 
participate (Baxter et al., 2011). Areas addressed in 
the questionnaire included safety at home, safety 
with driving, the ability to return to work, and the 
level of participation compared to life before the 
cancer diagnosis and treatment.  The questionnaire 
consisted of two yes/no questions, four questions to 
be ranked on a five-point Likert scale, and one open-
ended question.  Questions were as follows:  
• Do you have any trouble with memory, 
planning, or attention?   
• When you are home alone, do you feel 
safe?   
• Have you returned to work?   
• If yes, what percentage of your normal 
job functions are you able to do?   
• Do you drive?  
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 • If yes, do you feel you are as safe a 
driver as you were before being 
diagnosed with cancer?  
• Compared to your lifestyle prior to 
diagnosis, how has your participation in 
daily activities changed?  
Procedures 
The researchers recruited the participants 
through a convenience sample of Towson, 
Maryland, and Houston, Texas, area cancer 
survivors.  In Towson, the participants were 
recruited from a wellness center using a recruitment 
brochure, through personal contacts, and via a 
snowballing technique.  In Houston, participants 
were recruited through personal contacts, followed 
by a snowballing technique.  In both Towson and 
Houston, data collection occurred in a location that 
was convenient for each individual participant: quiet, 
free from distractions, and containing a table with 
two chairs.  The participants were provided the 
purpose of the study, in written form and verbally, 
and given an opportunity to ask questions.  Then the 
participants were provided with an informed 
consent document, approved through the respective 
affiliated universities, and assigned a unique code 
number to maintain anonymity.  
Data collection began with each participant 
completing a self-report form for age, gender, race, 
diagnosis, time since diagnosis, time since last 
treatment, and type of treatment received.  Then, the 
researchers administered the MoCA and the RNLI-P, 
alternating the sequence to decrease the influence of 
one test on the other.  Data collection began in 
Towson, followed by data collection in Houston.  
During the data collection in Towson, many of the 
participants commented on how their participation in 
activities changed as a result of cancer and cancer 
treatment.  To capture this concept of change in 
activities and participation, the researchers decided to 
add a supplemental questionnaire for the Houston 
participants.  Therefore, only the Houston 
participants completed the supplemental 
questionnaire, which was administered in an 
alternating sequence with the MoCA and the RNLI-
P.   
Data Analysis 
 The researchers used SPSS version 17.0 for 
data analysis (SPSS, 2009).  Descriptive statistics 
were used to analyze the data.  Frequencies were 
calculated for diagnoses of cancers, types of 
treatment, time since last treatment, and highest 
level of education.  Total scores for the MoCA and 
the RNLI-P were calculated.  The prevalence of 
MCI was determined by identifying the number of 
participants who scored below 26 on the MoCA.  A 
correlation was done comparing the MoCA and the 
RNLI-P scores.   
The researchers used content analysis to 
analyze the participants’ responses to the 
supplemental questionnaire.  By definition, an MCI 
does not interfere with the ability to respond 
appropriately to inquiries.  The researchers 
constructed a case-by-variable matrix for the data, 
with a row for each participant and a column for 
each question of the questionnaire (Bernard, 2013).  
Responses to the open-ended question of the 
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 supplemental questionnaire were coded and 
assigned to categories.  Frequencies of data were 
then computed.    
Results 
The participants for the study included 35 
adult cancer survivors; 12 participants were from 
the Northeast (Towson), and 23 participants were 
from the South (Houston).  Demographic data for 
the participants are shown in Table 1.  The 
educational backgrounds of the participants were as 
follows: seven (20%) had completed high school, 
six (17.14%) had an associate’s degree, 11 
(31.42%) had a bachelor’s degree, six (17.14%) had 
a master’s degree, and five (14.30%) had a 
doctorate degree.  
Diagnostic and treatment modalities data are 
also shown in Table 1.  Data regarding recurrence 
were not available, as the participants were not 
asked if this was their first and only cancer 
occurrence.
 
Table 1 
Participant Demographic, Diagnosis, and Treatment Data (N = 35) 
 
Gender 
 Female 22 
 Male 13 
 
Age 
 20s 3 
 30s 2 
 40s 2 
 50s 8 
 60s 10 
 70s 7 
 80s 3 
 
Race 
 Caucasian 28 
 Asian 3 
 Hispanic 2 
 African American 1  
 Other 1 
 
Time Since Last Tx 
 0-1 year 13 
 1+-5 years 11 
 5+-10 years 4 
 10+ years 7 
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 Diagnosis 
 Breast 10 
 Colorectal 2 
 Other 8 
 Combination 7 
 Ovarian/Gynecological 1 
 Prostate 7 
 
Type of Tx 
 Chemotherapy 8 
 Radiation 4 
 Hormonal 3 
 Surgery 5 
 Chemotherapy + Radiation 9 
 Radiation + Hormonal 3 
 Multiple Treatments 3 
 
MoCA Scores 
 The scores obtained from the MoCA ranged 
from 20 to 29, with a mean score of 25.0 (SD ± 2.5).  
Of the 35 participants, 22 (62.9%) scored 25 or 
below, and 13 (37.1%) scored 26 or above.  The 
scores for each section were evaluated and 
compared with the total points possible in each 
section.  The three sections of the MoCA with the 
lowest percentage of correct scores were delayed 
recall (20%), visuospatial/executive function 
(37.1%), and language (45.7%).  Attention and 
abstraction both had scores of 57.1% correct.  
Naming and orientation both had scores of 91.4% 
correct.  
 A Pearson product-moment correlation 
coefficient was computed to assess the relationship 
between MoCA scores and time since last 
treatment.  As noted in Table 1, time since last 
treatment ranged from less than one year (n = 13) to 
10 or more years (n = 7).  There was no correlation 
between MoCA and time since last treatment [r = 
.102, p = .558]. 
RNLI-P Scores 
The scores on the RNLI-P ranged from six 
to 11 (Table 2), with a mean score of 9.64 (SD ± 
1.12).  Of the 35 participants, four (11.4%) scored 
an 11 on the RNLI-P, which indicated full 
reintegration into daily living.  The majority of the 
respondents indicated less than optimal integration.  
Of the specific statements asked, 29 (82.9%) 
disagreed with the statement, “I feel embarrassed 
when I am with other people.”  All other statements 
had fewer than four (11.4%) participants in 
disagreement.  The MoCA and the RNLI-P scores 
were compared and yielded a correlation of r = .04, 
p = .818. 
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 Table 2 
RNLI-P Scores Across Participants (N = 35) 
 
RNLI-P Scores 11 10 9 8 7 6 
Participants: n (%) 4 (11.43%) 23 (65.71%) 3 (8.57%) 3 (8.57%) 1 (2.86%) 1 (2.86%) 
 
Supplemental Questionnaire Responses 
Twenty-one of the 23 Houston participants 
answered the supplemental questionnaire.  
Seventeen (80.95%) answered yes to the question, 
“Do you have any trouble with memory, planning, 
or attention?” Eight (38.1%) reported a little, four 
(19.05%) reported somewhat, three (14.29%) 
reported much, and two (9.52%) reported a great 
deal.  Of the 17 participants who self–reported 
changes in cognition, 10 (58.8%) had scored 25 or 
below on the MoCA and had a mean RNLI-P score 
of 8.9 (SD ± 1.59).  Conversely, there were seven 
who self-reported difficulties with cognition, but 
who also had MoCA scores of 26 or above, 
indicating a possible misperception of cognitive 
changes. 
Four categories were developed from the 
coded responses to the open-ended question in the 
supplemental questionnaire (Table 3).  Decreased 
participation was the most frequently reported 
change; the participants stated it was due to 
decreased energy or fatigue and/or taking longer to 
perform activities.  Three participants reported that 
they were “very tired most days,” while two 
participants expressed that they “took more naps.”  
One participant eloquently summed up what many 
of the others expressed with the statement, “slower, 
less energy in general.”  
 
Table 3 
Summary of Participant Responses to Supplemental Questionnaire by Category (n = 21) 
  
 Category  Number of Responses Percentages* 
  
Decreased participation; decreased energy 
and/or takes more time to complete activities 
 
11/21 
 
52.38% 
  
More selective in activities 
 
8/21 
 
38.09% 
  
Balance in activities 
 
5/21 
 
23.81% 
  
Cognitive changes  
 
4/21 
 
19.04% 
Note. The supplemental questionnaire was administered to Houston participants only. Twenty-one of the 23 participants 
answered the supplemental questionnaire. 
*Percentages total more than 100%; some participants identified more than one category of concern. 
8
The Open Journal of Occupational Therapy, Vol. 2, Iss. 2 [2014], Art. 2
https://scholarworks.wmich.edu/ojot/vol2/iss2/2
DOI: 10.15453/2168-6408.1080
 The next largest number of responses related 
to being more selective in activities in which to 
participate.  The World Health Organization 
(WHO) defines participation as “involvement in a 
life situation” (World Health Organization, 2001, p. 
10).  So a change in participation for this study was 
defined as a change (sometimes a decrease) in 
involvement in a life situation.  One participant 
described that he/she “stopped participating in 
previous organizations.”  Another participant 
expressed that he/she “could not devote the time 
needed for school [college courses].”  
 Five participant comments were categorized 
as striving for a balance in activities.  This was 
evident when one participant expressed the “need 
for more balance in life.”  Another participant 
related the need to “plan ahead” or schedule daily 
activities, while another expressed that he/she “tried 
to maintain all daily activities.”  
Four participants reported cognitive changes 
that interfered with their participation.  These 
included decreased memory, concentration, 
comprehension, and the ability to multitask.  
Discussion 
The purposes of this study were to identify 
the cognitive status in cancer survivors 
posttreatment, determine how those changes 
affected their function and participation in daily life 
activities, and explore how cancer survivors 
perceived changes in their cognition.  The results 
established that a significant percentage of the 
cancer survivors believed they had trouble with 
memory, planning, or attention.  These findings 
support previous studies in which cancer survivors 
self-reported or presented with symptoms of MCI 
(Ahles & Saykin, 2001; Baxter et al., 2011; Reid-
Arndt et al., 2010; Shilling & Jenkins, 2007; 
Tannock et al., 2004; Von Ah et al., 2009).  
No correlation was found between the 
MoCA scores and the RNLI-P scores.  It is possible 
that the RNLI-P is not sensitive enough to detect 
subtle changes and allow for correlation analysis.  
Although the analysis showed no relationship 
between the MoCA and the RNLI-P scores, 31 of 
the 35 participants had scores on the RNLI-P that 
indicated that they believed they were not 
reintegrated into normal living.  These results 
suggest that cancer survivors have potential 
difficulty in returning to normal routines.  This is 
supported in the literature, which indicates that 
people with memory difficulties experience 
problems participating in normal routines, work, 
and social functions (Artero et al., 2001; Farias et 
al., 2006; Perneczky et al., 2006). 
 Performance skills that decrease 
participation in daily life are areas of concern for 
occupational therapy practitioners (American 
Occupational Therapy Association [AOTA], 2008).  
The lowest percentages of correct scores on the 
MoCA were delayed recall (memory), executive 
function, and language, all indicating areas of most 
difficulty in cognition.  In addition, 80.95% of the 
participants who answered the supplemental 
questionnaire reported difficulty with memory, 
planning, and attention.  According to the 
Occupational Therapy Practice Framework (OTPF) 
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 (AOTA, 2008), attention, memory, perception, and 
thought are considered body functions under client 
factors.  Delayed recall is necessary for an 
individual to plan and manage the performance of 
an activity.  Furthermore, an individual needs 
executive functioning to identify possible solutions 
for a proposed problem in daily functioning.  These 
specific mental functions affect the performance 
skills clients use to participate in daily occupations. 
By definition, a determinant of MCI is that 
there is minimal or no change in abilities and 
participation in basic routines and IADLs, even 
though there is a change in cognition.  However, 
research suggests a link between MCI and 
impairments in IADLs (O’Connor et al., 2010; 
Okonkwo et al., 2006).  The present study offers 
insight on the specific IADLs that have the potential 
to be problematic for cancer survivors: performance 
at work; formal educational participation; 
community mobility (e.g., driving); and social 
participation with community, family, and peers.  
Overall, this study shows a decrease in life 
participation, as evidenced by 88.57% of the 
participants reporting 10 or less on the RNLI-P and 
therefore indicating decreased participation and 
changes in integration into daily living.  These 
results support work by Lyons, Lambert, Balan, 
Hegel, and Bartels (2013), which found that 
changes in activity and participation level were 
frequent in older cancer survivors.   
Limitations 
 The results of this study are preliminary and 
should be interpreted with caution.  A small sample 
size (N = 35), the large range of the participants’ 
ages, and the large range of time since last treatment 
detract from the interpretability of the study.  Given 
the size of the sample, there is not enough power for 
generalization to the population.  In addition, the 
use of two different locations, with no attempt to 
control for a specific diagnosis or a specific time 
since treatment, contributes to the study’s 
limitations.  Recruitment and data collection 
procedures varied at the two locations.  This may 
have affected the study’s results, although the 
researchers judge the probability of this unlikely as 
the tests used do not require stringent procedures.  
 A number of the participants (28.6%) were 
aged 70 years and older.  Cognitive decline with 
aging is a frequent concern in research with older 
adults, and age-related cognitive decline may have 
contributed to the results of the study.  However, as 
previously mentioned, the MoCA has been 
demonstrated to be sensitive in identifying MCI in 
aging adults when they are compared to age-
matched controls and age-matched persons 
diagnosed with dementia (Nasreddine et al., 2005). 
Also, three of the 10 participants aged 70 years and 
older had MoCA scores above 26.   
A further limitation is that researchers did 
not obtain the participants’ prior level of cognitive 
functioning.  Several studies have indicated that 
obtaining a baseline for cognition in the cancer 
population is difficult because the psychological 
effects of stress, anxiety, and depression related to a 
cancer diagnosis can result in cognitive changes 
(Vardy, Rourke, & Tannock, 2007).  Therefore, 
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 although decreased cognitive status is evident in 
many cancer survivors, it is difficult to attribute 
changes in cognitive status specifically to cancer 
and cancer treatments. 
The range of time since last treatment varied 
from less than one year to 34 years, and seven 
participants reported 10 or more years since their 
last treatment.  Given this wide range of time, it is 
possible that recognition of changes in cognition 
and function specifically attributable to the cancer 
and treatment may not be accurate.  Yet, there was 
no correlation found between time since treatment 
and MoCA score [r = .102, p = .558].  Some 
participants who were five to 10 years posttreatment 
had some MCI, and some who were fewer than five 
years posttreatment had no MCI.   
Finally, a limitation is that question number 
10 on the RNLI-P is worded in a negative manner 
compared to the other questions on the RNLI-P.  
Question 10 reads, “I feel embarrassed when I am 
with other people.”  Since this is the only question 
worded with a negative slant, if it is not read 
carefully, respondents might inadvertently pick 
“agree” even if they are functioning and integrated 
into their previous daily routines.  This phenomenon 
might have negatively affected RNLI-P scores by 
lowering them artificially.  It is also possible that 
the RNLI-P is not sensitive enough to capture the 
difficulties verbalized by cancer survivors.  
Implications for Occupational Therapy Practice 
The results of this study suggest several 
practice implications.  First, persons who are living 
following cancer diagnosis and treatment should be 
evaluated for cognitive impairment and for 
participation in activities of daily living and IADLs.  
The areas of increased difficulty include 
visuospatial/executive functioning, delayed recall, 
and language.  The OTPF (AOTA, 2008) defines 
each of these cognitive functions as necessary for 
task completion.  Further, they are important for 
participation in habitual and nonhabitual activities.  
In addition, occupational therapy should include 
strategies and interventions to improve or 
compensate for changes in cancer survivors’ 
cognitive skills.   
Many participants in this study indicated 
that increased fatigue and increased time needed to 
complete activities contributed to decreased 
participation in activities.  Therefore, it is 
imperative that practitioners address these concerns.  
Occupational therapy for post-cancer care 
individuals with MCI should include interventions 
to increase participation in activities of daily living 
and IADLS, with strategies such as activity and/or 
contextual modifications, pacing, and energy 
conservation techniques. 
Much of the literature indicates that changes 
in daily tasks are frequent side effects of cancer and 
cancer treatments (Chirikos, et al., 2002; O’Connor 
et al., 2010; Okonkwo et al., 2006; Rosenberg et al., 
2009).  Furthermore, changes in activity, 
participation level, and routines are frequent in 
older cancer survivors (Lyons et al., 2013).  
However, there has been little written to indicate 
that there are changes in activities, participation, 
and routines for younger persons as a result of 
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 cancer and cancer treatments.  This study suggests 
that changes in participation, including needing 
more time for engaging in activities, being more 
selective in activities, and trying to find a balance in 
participation, are a result of cancer and cancer 
treatments.  Yet, not all of the changes in 
participation were negative.  Several of the 
participants suggested changes in participation that 
they perceived as beneficial, including an increased 
spirituality.  The implication is that all areas of 
occupation, including work engagement, social 
participation, leisure activities, and rest, are 
important factors in the occupational therapy 
assessment.  
Many of the study participants offered 
comments and insights related to changes in 
activities and participation.  Occupational therapy 
practitioners can assist clients in evaluating their 
selection of activities and participation, including 
finding a balance of activities. Practitioners can help 
clients reflect on their occupational profile; examine 
current priorities, abilities, concerns, and risks; and 
find community engagement activities that fit their 
priorities and abilities.   
 Practitioners need to be aware of the 
possible cognitive dysfunctions cancer survivors 
may be experiencing.  Also, practitioners need to 
recognize the particular areas of cognitive 
dysfunction that are prevalent in cancer survivors.  
This awareness can lead to effective evaluation and 
treatment by occupational therapy practitioners, 
ultimately increasing their clients’ participation in 
daily life.  Since cancer survivors also experience 
other health conditions, such as hip replacement, 
arthritis, or stroke, understanding related cognitive 
dysfunctions can also assist practitioners when 
encountering such patients.   
Future Research 
Suggestions for future studies include the 
need for a large-scale study of MCI in cancer 
survivors across specific diagnoses, and the need to 
examine the influence of gender, race, and age.  A 
longitudinal study would be ideal for determining 
the long-term cognitive effects of cancer treatment, 
yet a cross-sectional study with a larger population 
would be more feasible and would generate similar 
data.   In addition, researchers should examine the 
relationship among specific cancer treatments and 
MCI, and determine the best instrument to measure 
participation in daily routines.  Last, but most 
important, it is necessary to establish best practices 
to increase participation in everyday activities for 
cancer survivors experiencing MCI.  
Conclusion 
 The results of this study add to the growing 
body of knowledge indicating that cancer survivors 
show MCIs, specifically in memory, executive 
function, and visual/spatial processing.  There also 
appears to be a connection between MCI and a self-
reported decrease in participation in daily activities, 
specifically IADLs. These findings suggest that 
rehabilitation for cancer survivors should include an 
evaluation for cognitive function and interventions 
that focus on the promotion of strategies to improve 
function and increase participation in daily routines.  
As the number of cancer survivors increases, 
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 occupational therapy practitioners can play an 
important role in cognitive rehabilitation and 
reintegration into daily living.   
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